Attenuated Bovine Respiratory Syncytial virus
The present invention relates i.a. to Bovine Respiratory Syncytial Viruses that are not capable of expressing a functional SH-protein and/or G-protein due to a mutation in the genes encoding the said proteins. Furthermore, the invention relates to vaccines based upon such Bovine Respiratory Syncytial Viruses and to methods for the preparation of such vaccines. Also the invention relates to diagnostic test kits for discriminating wild-type Bovine Respiratory Syncytial Viruses from Bovine Respiratory Syncytial Viruses according to the invention and to methods for the discrimination between those viruses.
1. A Bovine Respiratory Syncytial Virus incapable of expressing a functional G-protein due to a mutation in the gene encoding said protein.
2. A vaccine for the protection of cattle against BRSV-infection, comprising:
a Bovine Respiratory Syncytial virus according to in claim 1 and
a pharmaceutically acceptable carrier.
3. The vaccine according to claim 2 , further comprises an adjuvant.
4. Vaccine according to claim 2 , wherein said vaccine is in a freeze-dried form.
5. A method for the preparation of a vaccine for the protection of cattle against Bovine Respiratory Syncytial Virus infection, comprising:
admixing the Bovine Respiratory Syncytial Virus according to claim 1 and
a pharmaceutically acceptable carrier.
6. An immunogenic composition, comprising:
the Bovine Respiratory Syncytial virus according to claim 1 .